Home Newsfeeds Keybanc Maintains Overweight on Terex, Lowers Price Target to $44

Keybanc Maintains Overweight on Terex, Lowers Price Target to $44

Keybanc analyst Todd Thomas maintains Terex (NYSE:TEX) with a Overweight and lowers the price target from $54 to $44.

byBenzinga Newsdesk

July 12, 2022

1 minute read

Keybanc analyst Todd Thomas maintains Terex (NYSE:TEX) with a Overweight and lowers the price target from $54 to $44.

SVB Leerink Maintains Market Perform on Alnylam Pharmaceuticals, Raises Price Target to $145

By Benzinga Newsdesk

November 7, 7:43 AM

SVB Leerink analyst Mani Foroohar maintains Alnylam Pharmaceuticals (NASDAQ:ALNY) with a Market Perform and raises the price target from $142 to $145.

ALNY

Investor Sentiment Improves As Nasdaq Jumps 250 Points

By Lisa Levin

September 12, 6:44 AM

The CNN Money Fear and Greed index moved to the "neutral" zone, after US stocks recorded their first weekly surge since mid-August. Wall Street recorded gains in the previous session driven by communication services and technology stocks. For the week, the Dow gained 2.7%, while the S&P 500 surged 3.6%.

AMZN

Merus Appoints Life Sciences Strategic And Financial Industry Veteran Greg Perry As Chief Financial Officer

By Benzinga Newsdesk

June 15, 8:04 AM

Merus N.V. (NASDAQ:MRUS), a clinical-stage oncology company developing innovative, full-length multispecific antibodies (Biclonics® and Triclonics®), today announced the appointment of Greg Perry as the

MRUS